Andrea Mayer-Mokler, Ph.D.

Vice President Global Head of Clinical Sciences

Andrea Mayer-Mokler joined Immatics in September 2005 and is responsible for Clinical Development and Clinical Operations in Europe.

Andrea has been in clinical development/operations all her professional life with increasing responsibilitiesAfter University she joined Merck Sharp & Dohme working as Manager Clinical Research on various indications. Thereafter she moved to Igeneon and entered the field of cancer immunotherapies. 14 years ago, Andrea joined Immatics as the first Clinical Study Director being responsible for several international cancer vaccine trials and leading the cross-functional project teams. She is currently responsible for clinical development of the ACT trials which are being conducted in US and Europe and clinical operations in Europe.

Andrea Mayer-Mokler holds a PhD in Tumor biology and Oncology from the Medical University of Vienna, a Master of Biotechnology from the University of Agricultural Sciences of Vienna and a MBA from the Webster University, Vienna, Austria.